medigraphic.com

2015, Number 3

<< Back Next >>

Rev Cuba Endoc 2015; 26 (3)

Some aspects of interest related to sarcopenic obestiy

Hernández RJ, Licea PME, Castelo Elías-Calles L

Language: Spanish
References: 64
Page: 263-277
PDF size: 197.86 Kb.


ABSTRACT

Some aspects of interest on sarcopenic obesity were described including concept, prevalence, diagnosis and consequences from the clinical viewpoint. To this end, several articles on this topic were reviewed, taking into account their quality and updating, according to the author's criteria. Obesity represents the changes in the muscle composition with reduction of its mass, which contributes to reduce its strength and performance, associated to fat infiltration in it. Its prevalence is variable according to the criteria applied for its diagnosis (4.4 for 84 % in men and 3.6 for 94 % in women) based on clinical and supplementary criteria. Its effects are few at the beginning but as time goes by, the physical performance diminishes, so it is difficult to perform daily activities leading to disability and dependence, greater use of hospital and social resources and low quality of life.


REFERENCES

  1. Casanova MC, Trasancos M. Ancianos con diabetes mellitus de tipo 2: retos actuales para la salud pública cubana. MEDISAN. 2013;17(8):2093-5.

  2. Jiménez SM, Díaz ME, García RG, Bonet M, Wong I. Cambios en el estado nutricional de la población cubana adulta de diferentes regiones de Cuba. Rev Cubana Hig Epidemiol. 2012;50(1):4-13.

  3. Díaz J. El envejecimiento de la población española. Investigación y Ciencia. 2010;34:42.

  4. Cardona D, Peláez E. Envejecimiento poblacional en el siglo XXI: oportunidades, retos y preocupaciones. Salud Uni Norte. Barranquilla (Col.). 2012;28(2):335-48.

  5. OMS. Obesidad y sobrepeso. Nota descriptiva N° 311, enero de 2014 [homepage en Internet]; 2014 [citado 5 de octubre de 2014]. Disponible en: http://www.who.int/mediacentre/factsheets/fs311/es

  6. Soo L, Jung HK, Ji WY, Seon MK, Sung HCh, Young JP, et al. Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care. 2010;33(7):1652-4.

  7. Jiménez SM, Rodríguez A, Díaz ME. La obesidad en Cuba. Una mirada a su evolución en diferentes grupos poblacionales. Rev Cubana Aliment Nutr. 2013;23(2):297-308.

  8. Cuba. Minsap. Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario estadístico de salud; 2011 [homepage en Internet]. La Habana, Minsap; 2012 [citado 12 de agosto de 2014]. Disponible en: http://files.sld.cu/bvscuba/files/2012/05/anuario-2011-e.pdf

  9. Walston JD. Sarcopenia in older adults. Current Opinion in Rheumatology. November 2012;24(6):623-7.

  10. Cruz-Jentoft AJ, Cuesta F, Gómez MC, López-Soto A, Masanés F, Matía P, et al. La eclosión de la sarcopenia: Informe preliminar del Observatorio de la Sarcopenia de la Sociedad Española de Geriatría y Gerontología. Rev Esp Geriatr Gerontol. 2011;46(2):100-10.

  11. Cruz-Jentoft A, Baeyens JP, Bauer JM, Cederholm T, Land F, Martin FC, et al. Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on Sarcopenia in Older People. Age Agenig. 2010;39:412-23.

  12. Cruz-Jentoft A, Landi F, Topinkova E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13:1-7.

  13. Paddon-Jones D, Short KR, Campbell WW, Volpi E, Wolfe RR, et al. Role of dietary protein in the sarcopenia of aging. Am J Clin Nutr. 2008;87:1562S-6S.

  14. Sayer AA, Syddall H, Martin H, Patel H, Baylis D, Cooper C. The developmental origins of sarcopenia. J Nutr Health Aging. 2008;12:427-32.

  15. Critchley M. The neurology of old age. Lancet. 1931;217:1331-7.

  16. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127:990S-1S.

  17. Cai D, Frantz JD, Tawa Jr NE, Melendez PA, Oh BC, Lidov HG, et al. IKK beta/NF-kappa B activation causes severe muscle wasting in mice. Cell. 2004;119:285-98.

  18. Johnston AP, De Lisio M, Parise G. Resistance training, sarcopenia, and the mitochondrial theory of aging. Appl Physiol Nutr Metab. 2008;33:191-9.

  19. Cruz-Jentoft A, Baeyens JP, Bauer JM, Cederholm T, Land F, Martin FC, et al. Reproducibility of an isokinetic strength-testing protocol of the knee and ankle in older adults. Gerontology. 2009;55:259-68.

  20. Ling CHY, Taekema D, de Craen AJM, Gussekloo J, Westendorp RGJ, Maier AB. Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study. CMAJ. 2010;182(5):429-35.

  21. Bean JF, Kiely DK, Herman S, Leveille SG, Mizer K, Frontera WR, et al. The relationship between leg power and physical performance in mobility-limited older people. J Am Geriatr Soc. 2002;50:461-7.

  22. Kim J, Davenport P, Sapienza C. Effect of expiratory muscle strength training on elderly cough function. Arch Gerontol Geriatr. 2009;48:361-6.

  23. Figueiredo PA, Powers SK, Ferreira RM, Appell HJ, Duarte JA. Aging impairs skeletal muscle mitochondrial bioenergetic function. J Gerontol A Biol Sci Med Sci. 2009;64:21-33.

  24. Working Group on Functional Outcome Measures for Clinical Trials. Functional outcomes for clinical trials in frail older persons: time to be moving. J Gerontol A Biol Sci Med Sci. 2008;63:160-4.

  25. Benton M, Whyte MD, Dyal BW. Sarcopenic Obesity: Strategies for Management. AJN. 2011;111(12):38-44.

  26. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629-35.

  27. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008;11:693-700.

  28. Serra JA. Consecuencias clínicas de la sarcopenia. Nutr Hosp. 2006;21(3):46-50.

  29. Gómez A, Rodríguez V, Vila S, Casajús JA, Ara I. Aging and body composition: the sarcopenic obesity in Spain. Nutricion Hospitalaria. 2012;27(1):22-30.

  30. Cruz-Jentoft AJ, Cuesta F, Gómez MC, López-Soto A, Masanés F, Matía P, et al. La eclosión de la sarcopenia: Informe preliminar del Observatorio de la Sarcopenia de la Sociedad Española de Geriatría y Gerontología. Rev Esp Geriatr Gerontol. 2011;46(2):100-10.

  31. Lee S, Kim TN, Kim SH. Sarcopenic obesity is more closely associated with knee osteoarthritis than is non-sarcopenic obesity: A cross-sectional study. Artritis & Rheumatism. December 2012;64(12):3947-54.

  32. Baumgartner RN. Body composition in healthy aging. Ann NY Acad Sci. 2000;904:437-48.

  33. Davison KK, Ford ES, Cogswell ME, Dietz WH. Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc. 2002;50:1802-9.

  34. Zoico E, Di Francesco V, Guralnik JM, Mazzali G, Bortolani A, Guariento S, et al. Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int J Obes Relat Metab Disord. 2004;28:234-41.

  35. Gómez A, Pedrero R, Olivares PR, Luzardo L, Juez A, Mata E, et al. Prevalence of overweight and obesity in non-institutionalized people aged 65 or over from Spain: the elderly EXERNET multi-centre study. Obes Rev. 2011;12(8):583-92.

  36. Kim TN, Yang SJ, Yoo HJ, Lim KI, Kang HJ, Song W, et al. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes. 2009;33:885-92.

  37. Kim YS, Lee Y, Chung YS, Lee DJ, Joo NS, Hong D, et al. Prevalence of Sarcopenia and Sarcopenic Obesity in the Korean Population Based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci. 2012;67(10):1107-13.

  38. Kim TN, Park MS, Lim KI, Choi HY, Yang SJ, Yoo HJ, et al. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study. Clinical Endocrinology. 2013;78(4):525-32.

  39. Hwang B, Lim JY, Lee J, Choi NK, Ahn YO, Park BJ. Prevalence Rate and Associated Factors of Sarcopenic Obesity in Korean Elderly Population. J Korean Med Sci. 2012;27(7):748-55.

  40. Batsis JA, Barre LK, Mackenzie TA, Pratt SI, Lopez F, Bartels SJ. Variation in the Prevalence of Sarcopenia and Sarcopenic Obesity in Older Adults Associated with Different Research Definitions: Dual-Energy X-Ray Absorptiometry Data from the National Health and Nutrition Examination Survey 1999-200. Journal of the American Geriatrics Society. 2013;61(6):974-80.

  41. Fuenmayor RE, Villabón G, Saba T. Sarcopenia-Vison clínica de una entidad poco conocida y mucho menos buscada. Rev Venez Endocrinol Metab. 2007;5(1):3-7.

  42. Rolland Y, Czerwinski S, Abellan Van Kan G, Morley JE, Cesari M, et al. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12:433-50.

  43. Marjolein V, Laura A. Consequences of Sarcopenia. Clin Geriatric Med. 2011;27(3):387-99.

  44. Del Pino Montes J, Corral L, Sánchez MD, Calero I, Carranco TE, Quesada Moreno A. Enfermedad ósea de Paget, osteomalacia y sarcopenia. Medicine- Programa de Formación Médica Continuada. Acreditado June 2014;11(60):3555-66.

  45. Gómez A, Vicente G, Vila S, Casajús JÁ, Ara I. Envejecimiento y composición corporal: la obesidad sarcopénica en España. Nutr Hosp. 2012;27(1):22-30.

  46. Ormsbee MJ, Prado CM, Ilich JZ, Purcell S, Siervo M, Folsom A, et al. Osteosarcopenic obesity: the role of bone, muscle, and fat on health. Journal of Cachexia, Sarcopenia and Muscle. 2012;5(3):183-92.

  47. DECODE study group. Age and sex specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2003;26:61-9.

  48. Alonso JCD. Prevalencia de diabetes mellitus en pacientes geriátricos institucionalizados en la provincia de Cádiz. Estudio Diagerca. Rev Esp Geriatr Gerontol. 2012;47(3):114-8.

  49. Martínez N, Vilches A. Conferencia de consenso: Tratamiento de la diabetes tipo 2 en el paciente anciano. Med Clin (Barc). 2014;142:89-90.

  50. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ, et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care. 2010;33:1652-4.

  51. Capel F, Rimbert V, Lioger D, Diot A, Rousset P, Patureau Mirand P, et al. Due to reverse electron transfer, mitochondrial H2O2 release increases with age in human vastuslate-ralis muscle although oxidative capacity is preserved. Mech Ageing Dev. 2005;126:505-11.

  52. McKenzie D, Bua E, McKiernan S, Aiken JM. Mitochondrial DNA deletion mutations: a causal role in sarcopenia. Eur J Biochem. 2002;269:2010-5.

  53. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan Ch, Rothman DL, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300:1140-2.

  54. Skov-Jensen C, Skovbro M, Flint A, Helge JW, Dela F. Contraction-mediated glucose uptake is increased in men with impaired glucose tolerance. Appl Physiol Nutr Metab. 2007;32:115-22.

  55. Khamseh ME, Malek M, Aghili R, Emami Z. Sarcopenia and diabetes: pathogenesis and consequences. British Journal of Diabetes & Vascular Disease. 2011;11:230.

  56. Ilich JZ, Kelly OJ, Inglis JE, Panton LB, Duque G, Ormsbee MJ. Interrelationship among muscle, fat, and bone: Connecting the dots on cellular, hormonal, and whole body levels. Ageing Research Reviews. May 2014;15:51-60.

  57. Hui W, Litherland GJ, Elias MS, Kitson GI, Cawston TE, Rowan AD, et al. Leptin produced by joint white adipose tissue induces cartilage degradation via up regulation and activation of matrix metalloproteinases. Ann Rheumatic Dis. 2012;71:455-62.

  58. Hu PF, Bao JP, Wu LD. The emerging role of adipokines in osteoarthritis: a narrative review. Mol Biol Rep. 2011;38:873-8.

  59. Gustafson D, Lissner L, Bengtsson C, Bjorkelund C, Skoog I. A 24-year followup of body mass index and cerebral atrophy. Neurology. 2004;63(10):1876-81.

  60. Gustafson D, Steen B, Skoog I. Body mass index and white matter lesions in elderly women. An 18-year longitudinal study. International Psychogeriatrics. 2004;16(3):327-36.

  61. Levine ME, Crimmins EM. Sarcopenic Obesit y and Cognitive Functioning: The Mediating Roles of Insulin Resistance and Inflammation? Current Gerontology and Geriatrics Research. 2012: Article ID 826398.

  62. Sturman MT, De Leon CFM, Bienias JL, Morris MC, Wilson RS, Evans DA. Body mass index and cognitive decline in a biracial community population. Neurology. 2008;70(5):360-7.

  63. Calderín Bouza RO, Orlandi González NE. Síndrome metabólico vs. síndrome de insulinorresistencia. Diferentes términos, clasificaciones y enfoques: ¿existe o no? Rev Cubana Endocrinol [serie en Internet]. 2006 Dic [citado 25 de agosto de 2014];17(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561- 29532006000300006&lng=es&nrm=iso&tlng=es

  64. Yanes Quesada MÁ, Yanes Quesada M, Calderín Bouza R, Cruz Hernández J. Síndrome de insulinorresistencia, una amenaza para la salud. Rev Cubana Endocrinol [serie en Internet]. 2008 Dic [citado 25 de agosto de 2014];19(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561- 29532008000300006&lng=es&nrm=iso&tlng=es




2020     |     www.medigraphic.com